Antiarrhythmic Mechanisms of SK Channel Inhibition in the Rat Atrium
暂无分享,去创建一个
T. Jespersen | Lasse Skibsbye | M. Grunnet | B. Bentzen | M. Nielsen | Xiaodong Wang | S. H. Bomholtz | L. Axelsen
[1] Xiaozhi Cao,et al. Association between SNP rs13376333 and rs1131820 in the KCNN3 gene and atrial fibrillation in the Chinese Han population , 2014, Clinical chemistry and laboratory medicine.
[2] Lei Yuan,et al. Small-conductance calcium-activated potassium (SK) channels contribute to action potential repolarization in human atria. , 2014, Cardiovascular research.
[3] J. M. Di Diego,et al. Ranolazine Effectively Suppresses Atrial Fibrillation in the Setting of Heart Failure , 2014, Circulation. Heart failure.
[4] S. Mahida. Expanding role of SK channels in cardiac electrophysiology. , 2014, Heart rhythm.
[5] D. Terentyev,et al. Sarcoplasmic reticulum Ca²⁺ release is both necessary and sufficient for SK channel activation in ventricular myocytes. , 2014, American journal of physiology. Heart and circulatory physiology.
[6] S. Nattel,et al. Role of Small-Conductance Calcium-Activated Potassium Channels in Atrial Electrophysiology and Fibrillation in the Dog , 2014, Circulation.
[7] J. Weiss,et al. Apamin induces early afterdepolarizations and torsades de pointes ventricular arrhythmia from failing rabbit ventricles exhibiting secondary rises in intracellular calcium. , 2013, Heart rhythm.
[8] A. Ma,et al. Bisoprolol reversed small conductance calcium-activated potassium channel (SK) remodeling in a volume-overload rat model , 2013, Molecular and Cellular Biochemistry.
[9] B. Nguyen,et al. Heterogeneous Upregulation of Apamin‐Sensitive Potassium Currents in Failing Human Ventricles , 2013, Journal of the American Heart Association.
[10] A. Dolga,et al. KCa2 and KCa3 Channels in Learning and Memory Processes, and Neurodegeneration , 2012, Front. Pharmacol..
[11] N. Holstein-Rathlou,et al. Angiotensin II does not acutely regulate conduction velocity in rat atrial tissue , 2011, Scandinavian journal of clinical and laboratory investigation.
[12] J. Svendsen,et al. Screening of KCNN3 in patients with early-onset lone atrial fibrillation. , 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[13] U. Sørensen,et al. Effects on Atrial Fibrillation in Aged Hypertensive Rats by Ca2+-Activated K+ Channel Inhibition , 2011, Hypertension.
[14] U. Sørensen,et al. The Duration of Pacing-induced Atrial Fibrillation Is Reduced in Vivo by Inhibition of Small Conductance Ca2+-activated K+ Channels , 2011, Journal of cardiovascular pharmacology.
[15] J. Weiss,et al. Small-Conductance Calcium-Activated Potassium Channel and Recurrent Ventricular Fibrillation in Failing Rabbit Ventricles , 2011, Circulation research.
[16] N. Chiamvimonvat,et al. Cardiac Small Conductance Ca2+-Activated K+ Channel Subunits Form Heteromultimers via the Coiled-Coil Domains in the C Termini of the Channels , 2010, Circulation research.
[17] B. Fakler,et al. Ca2+-activated K+ channels: from protein complexes to function. , 2010, Physiological reviews.
[18] U. Sørensen,et al. Inhibition of Small-Conductance Ca2+-Activated K+ Channels Terminates and Protects Against Atrial Fibrillation , 2010, Circulation. Arrhythmia and electrophysiology.
[19] Thomas Meitinger,et al. Common Variants in KCNN3 are Associated with Lone Atrial Fibrillation , 2010, Nature Genetics.
[20] M. Poss,et al. Initial SAR studies on apamin-displacing 2-aminothiazole blockers of calcium-activated small conductance potassium channels. , 2008, Bioorganic & medicinal chemistry letters.
[21] P. Pedarzani,et al. Molecular and cellular basis of small- and intermediate-conductance, calcium-activated potassium channel function in the brain , 2008, Cellular and Molecular Life Sciences.
[22] H. Matsubara,et al. Generation of reentrant arrhythmias by dominant-negative inhibition of connexin43 in rat cultured myocyte monolayers. , 2008, Cardiovascular research.
[23] N. Holstein-Rathlou,et al. The Antiarrhythmic Peptide Analog ZP123 Prevents Atrial Conduction Slowing During Metabolic Stress , 2005, Journal of cardiovascular electrophysiology.
[24] José Jalife,et al. Mechanisms of Atrial Fibrillation Termination by Pure Sodium Channel Blockade in an Ionically-Realistic Mathematical Model , 2005, Circulation research.
[25] M. Stocker. Ca2+-activated K+ channels: molecular determinants and function of the SK family , 2004, Nature Reviews Neuroscience.
[26] Kuljit Singh,et al. Small and intermediate conductance Ca2+-activated K+ channels confer distinctive patterns of distribution in human tissues and differential cellular localisation in the colon and corpus cavernosum , 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.
[27] G. Wang,et al. State-dependent Block of Wild-type and Inactivation-deficient Na+ Channels by Flecainide , 2003, The Journal of general physiology.
[28] K. Harlow,et al. ZP123 Increases Gap Junctional Conductance and Prevents Reentrant Ventricular Tachycardia During Myocardial Ischemia in Open Chest Dogs , 2003, Journal of cardiovascular electrophysiology.
[29] Y. Park,et al. Ion selectivity and gating of small conductance Ca(2+)‐activated K+ channels in cultured rat adrenal chromaffin cells. , 1994, The Journal of physiology.
[30] Lammers Wj,et al. Pathophysiology of atrial fibrillation: current aspects. , 1993, Herz.
[31] N. Benowitz,et al. Poisoning Due to Class IA Antiarrhythmic Drugs , 1990 .
[32] A. K. Ritchie,et al. Tetraethylammonium ion sensitivity of a 35-pS Ca2+-activated K+ channel in GH3 cells that is activated by thyrotropin-releasing hormone , 1990, Pflügers Archiv.
[33] Stanley Nattel,et al. Novel Approaches for Pharmacological Management of Atrial Fibrillation , 2012, Drugs.
[34] S. Olesen,et al. Apamin interacts with all subtypes of cloned small-conductance Ca2+-activated K+ channels , 2000, Pflügers Archiv.
[35] Y. Kihara,et al. Mechanisms of negative inotropic effects of class Ic antiarrhythmic agents: comparative study of the effects of flecainide and pilsicainide on intracellular calcium handling in dog ventricular myocardium. , 1996, Journal of cardiovascular pharmacology.
[36] N. Benowitz,et al. Poisoning due to class IA antiarrhythmic drugs. Quinidine, procainamide and disopyramide. , 1990, Drug safety.